Directorate Change

RNS Number : 8158I

Syntopix Group plc

21 June 2011

 



Press Release

21 June 2011

Syntopix Group plc

("Syntopix", "the Company")

Directorate Change

Syntopix Group plc (AIM:SYN), the antimicrobial experts delivering healthcare innovation to the cosmetic, consumer healthcare and pharmaceutical industries, announces that Dr. Jonathan Cove will resign as a director of the Company, effective from 1 July 2011.

Dr. Cove will continue as an employee of the Company for a further three months until 30 September 2011.

Dr. Stephen Jones commented: ''The board would like to thank Dr. Cove for his loyal service and contribution to the Company over the years and wishes him well in the future."

- Ends -

For further information, please contact:

Syntopix Group plc
Dr Stephen Jones, Chief Executive Officer	Tel: [phone]
Tom Bannatyne, Chairman	www.syntopix.com
Zeus Capital Ltd
Alex Clarkson	Tel: [phone]
Tom Rowley	www.zeuscapital.co.uk
XCAP Securities Plc
Karen Kelly/Jon Belliss/Parimal Kumar	Tel: [phone]
	www.xcapgroup.co.uk

Media enquiries:

Abchurch Communications
Sarah Hollins/Simone Elviss/ Adam Michael	Tel: [phone]
[e-mail]	www.abchurch-group.com

 

END

 

 

BOAGCGDLLSDBGBB